NAFLD stands for Non-Alcoholic Fatty Liver Disease. A new study conducted on the subject matter of this disease suggests that the low-levels of the amino acids in this disease might hold the key to the treatment for the diseases. This chronic liver disease currently does not have therapy or a drug for the cure of it. However, the low-glycine circulated blood in the patients’ body can become a future for the potential medical treatment to generate a glycine-based treatment. The glycine-based treatment to the NAFLD patients can attenuate the hepatic fatty acids and cause the synthesis of the clinical evolution.